The global cardiac surgery instrument market size was valued at US$ 1.70 billion in 2023 and is expected to reach US$ 2.23 billion by 2030, growing at a compound annual growth rate (CAGR) of 3.9% from 2023 to 2030.
The cardiac surgery instrument market has been experiencing significant growth and innovation in recent years. As medical technology advances and surgical techniques become more refined, the demand for specialized instruments tailored to cardiac surgeries has surged. This market encompasses a wide range of tools and devices used during procedures such as coronary artery bypass grafting, valve replacements, and heart transplants. The market's expansion is driven by factors such as the rising prevalence of cardiovascular diseases, the aging population, and increasing awareness about advanced treatment options. Manufacturers are focusing on developing instruments that are not only precise and effective but also minimally invasive, leading to quicker recovery times and reduced postoperative complications. The market's dynamism is underscored by ongoing research and development efforts, which aim to create cutting-edge instruments that enhance surgical precision, patient outcomes, and overall procedural efficiency.
Amidst this growth, several trends have emerged in the cardiac surgery instrument market. One notable trend is the integration of robotics and advanced imaging technologies into surgical procedures. These innovations allow surgeons to perform complex cardiac surgeries with higher precision and lower invasiveness, leading to improved patient experiences.
Cardiac Surgery Instrument Market Regional Insights
North America: North America is the largest market for cardiac surgery instrument, accounting for a share of over 35.0% in 2023 North America has historically been a major market for cardiac surgery instruments due to the presence of advanced healthcare infrastructure, skilled medical professionals, and a high prevalence of cardiovascular diseases. The U.S. and Canada are key contributors to the market. Technological innovations and a focus on minimally invasive procedures have driven market growth in this region.
Europe: Europe is the second-largest market for cardiac surgery instrument, accounting for a share of over 21.4% in 2022. Europe is another significant market for cardiac surgery instruments. Countries like Germany, France, and the U.K. have well-established healthcare systems that support the demand for these instruments. The region also emphasizes research and development in medical technology, leading to the introduction of cutting-edge surgical tools and techniques.
Asia-Pacific: Asia Pacific is the fastest-growing market for cardiac surgery instrument, accounting for a share of over 29.5% in 2022. The Asia-Pacific region has shown rapid growth in the healthcare sector, including cardiac surgery. Countries like China, India, Japan, and South Korea have witnessed an increase in healthcare spending, leading to improved healthcare facilities and greater access to advanced medical equipment. Rising cardiovascular disease rates and an aging population have also contributed to the demand for cardiac surgery instruments.
Figure 1. Global Cardiac Surgery Instrument Market Share (%), by Region, 2023
The global cardiac surgery instrument market is poised to witness steady growth over the forecast period driven by the increasing prevalence of cardiovascular diseases and growing number of cardiac surgeries performed worldwide. The rising geriatric population who are more prone to heart conditions will further propel the demand for cardiac surgery instruments. Additionally, the development of advanced and innovative cardiac surgery instruments by key players to facilitate complex surgeries is expected to boost market growth. North America currently dominates the global market owing to high awareness regarding cardiovascular disorders and a well-established healthcare infrastructure in the region. However, Asia Pacific is likely to emerge as the fastest growing market during the next five years supported by improving medical facilities, rising healthcare spending and increasing focus of global players to tap opportunities in emerging Asian countries.
On the flip side, high costs associated with cardiac surgery procedures and instruments might restrict market expansion to some extent. Maintaining sterility of instruments during long and complex surgeries poses operational challenges for both surgeons and instrument manufacturers. Furthermore, lack of reimbursements in developing nations can hamper the volumes to certain level. Nevertheless, growing medical tourism across Asia will create new windows of opportunities for innovators. Key players are investing heavily in R&D to develop single-use and miniaturized instruments in order to increase affordability for patients globally. Modular and multifunctional products are expected to gain more traction going forward.
Cardiac Surgery Instrument Market Drivers:
Rising Cardiovascular Disease Prevalence: The increasing incidence of cardiovascular diseases, including coronary artery diseases, heart valve disorders, and congenital heart defects, was driving the demand for cardiac surgery instruments. As the global population ages and risk factors like obesity and diabetes become more prevalent, the need for cardiac surgeries and interventions rises.
Technological Advancements: Continuous advancements in medical technology have led to the development of more precise, minimally invasive, and effective cardiac surgery instruments. Innovations such as robotic-assisted surgeries, advanced imaging techniques, and improved catheter-based interventions have expanded the range of treatment options and improved patient outcomes.
Growing Awareness and Healthcare Access: Improved access to healthcare services and increasing awareness about heart health have led to earlier diagnosis and intervention for cardiovascular diseases. This has resulted in a higher number of surgeries and procedures, subsequently driving the demand for cardiac surgery instruments.
Aging Population: The global aging population has contributed to the rising incidence of heart diseases, as age is a significant risk factor for many cardiac conditions. Elderly individuals often require various cardiac interventions, from valve replacements to bypass surgeries, which boosts the demand for cardiac surgery instruments.
Cardiac Surgery Instrument Market Opportunities:
Technological Innovation: Ongoing advancements in medical technology provide opportunities to develop more sophisticated and efficient cardiac surgery instruments. This includes the development of robotic-assisted surgical systems, advanced imaging techniques, and tools that enable more precise and minimally invasive procedures.
Minimally Invasive Procedures: The trend towards minimally invasive procedures in cardiac surgery presents a significant opportunity. Developing instruments that allow for smaller incisions, reduced tissue trauma, and quicker recovery times can lead to increased patient satisfaction and improved outcomes.
Personalized Medicine: The concept of personalized medicine, tailoring treatments to an individual's unique characteristics, offers opportunities in the cardiac surgery instrument market. Instruments and technologies that enable personalized treatment plans based on a patient's genetic makeup, medical history, and specific cardiovascular condition can lead to more effective interventions.
Global Market Expansion: As emerging economies invest in healthcare infrastructure, there's an opportunity for cardiac surgery instrument manufacturers to expand their presence in these markets. This includes providing training and education to healthcare professionals and adapting products to suit the specific needs and resource constraints of different regions.
Cardiac Surgery Instrument Market Report Coverage
Report Coverage
Details
Base Year:
2022
Market Size in 2023:
US$ 1.70 Bn
Historical Data for:
2018 to 2022
Forecast Period:
2023 - 2030
Forecast Period 2023 to 2030 CAGR:
3.9%
2030 Value Projection:
US$2.23 Bn
Geographies covered:
North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa
Minimally Invasive Procedures: The trend toward minimally invasive cardiac procedures was on the rise. Patients and healthcare providers were increasingly seeking procedures with smaller incisions, reduced pain, shorter recovery times, and fewer complications. This trend was driving the development of specialized instruments designed for minimally invasive cardiac surgeries.
Robotics and Technology Integration: Robotic-assisted surgeries were gaining traction in the field of cardiac surgery. Surgeons were using robotic systems to perform complex procedures with enhanced precision and control. The integration of technology, including advanced imaging systems and virtual reality tools, was also improving surgical planning and execution.
Hybrid Procedures: Hybrid procedures, which combine traditional surgical techniques with catheter-based interventions, were becoming more common. These procedures allow for a tailored approach to each patient's condition, combining the strengths of both surgical and interventional techniques. Specialized instruments were being developed to facilitate these hybrid procedures.
Patient-Specific Solutions: Advances in medical imaging and 3D printing were enabling the creation of patient-specific models and instruments. Surgeons could plan procedures using detailed anatomical models and even have custom instruments designed for specific patients, optimizing surgical outcomes.
Cardiac Surgery Instrument Market Restraints:
Limited Reimbursement Policies: In some regions, reimbursement policies for cardiac surgeries and associated instruments may not fully cover the costs, especially for innovative and advanced technologies. This can hinder the adoption of new instruments by healthcare providers and limit market growth.
Skill and Training Requirements: Performing cardiac surgeries requires specialized training and expertise. The adoption of new instruments and techniques often necessitates additional training for medical professionals, which can be time-consuming and expensive.
Regulatory Challenges: Stringent regulatory processes and requirements for medical devices can lead to delays in getting new cardiac surgery instruments to market. Meeting regulatory standards while ensuring safety and efficacy can pose challenges for manufacturers.
Figure 2. Global Cardiac Surgery Instrument Market Share (%), by Product Type, 2023
On October 23, 2023, Medtronic plc., a global leader in healthcare technology, has received U.S. Food and Drug Administration (FDA) approval for the Aurora EV-ICD MRI SureScan (Extravascular Implantable Cardioverter-Defibrillator) and Epsila EV MRI SureScan defibrillation lead to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest (SCA).
On August 1, 2023, Teleflex Incorporated, a global provider of medical technologies, has announced the U.S Food and Drug Administration (FDA) has cleared the QuikClot Control Hemostatic Device to include mild and moderate bleeding in cardiac surgical procedures and bone surface bleeding following a sternotomy. This allows clinicians to use the QuikClot Control Device to control all bleeding in cardiac surgical procedures.
On September 12, 2023, CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, has announced the U.S. FDA clearance of the CorVista System with CAD Add-On to evaluate the presence of significant coronary artery disease as an aid in diagnosis.
Collaboration
On January 25, 2023, Terumo Corporation, is a global leader in medical technology and Siemens Healthineers, India, a company which provides healthcare solutions and services has collaboration for strengthening cardiac care in India through physician training and development, access to advanced medical technologies, and improved penetration of Tier 2 and 3 cities. The collaboration will flag off its efforts with a customized training program for Cathlab professionals, being developed in partnership with an eminent academic institute in India.
On October 13, 2023, GE Healthcare, a global medical technology company, and intravascular ultrasound (IVUS) market leader Boston Scientific Corporation has announced a collaboration that enables improved intravascular ultrasound (IVUS) workflow between the GE Healthcare Innova Cardiovascular X-ray System and the Boston Scientific iLab Ultrasound Imaging System.
Top Companies in Cardiac Surgery Instrument Market
Medtronic
Murray Surgical
SternMed GmbH
CARDIC INSTRUMENTS
Edwards Lifesciences Corporation.
Abbott
Boston Scientific Corporation
LivaNova, Inc.
Terumo Corporation
Getinge
Artivion, Inc
MicroPort Scientific Corporation
Braun SE
Stryker
Definition: Cardiac surgery instruments are specialized medical devices and tools designed for use during surgical procedures related to the heart and cardiovascular system. These instruments assist surgeons in performing various cardiac interventions, including coronary artery bypass grafting, heart valve repair/replacement, and other procedures aimed at treating heart conditions.
Share
About Author
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
U.S.: 
U.K. : 
India : 